CREATE MEDICINES: RECEIVES APPROVAL TO INITIATE FIRST-IN-HUMAN PHASE 1/2 CLINICAL TRIAL OF IN VIVO CAR-T CANDIDATE CRT-402 FOR AUTOIMMUNE DISEASES

Reuters · 2d ago

Please log in to view news